NHF Provides Expanded Coverage for More Chronic Diseases

The National Health Fund (NHF) has added four new chronic conditions for financial support – heart failure, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), and bladder cancer.

This has brought the total number of conditions now covered to 28.

Heart failure affects an estimated 117,500 Jamaicans and continues to drive increasing hospitalisations each year.

By providing subsidies for approximately 25 medications and supporting diagnostic services such as ECG, the NHF is helping patients better manage their condition, reduce complications, and avoid costly hospital admissions. The targeted intervention represents an annual investment of approximately $55 million, reinforcing a commitment to both patient care and health system sustainability.

COPD is one of the leading causes of death globally and affects tens of thousands of Jamaicans. With the expansion in coverage, patients living with this chronic respiratory condition will benefit from subsidised pharmaceutical treatment for long-term management.

The initiative, supported by an estimated $60 million, ensures that individuals can maintain a better quality of life while reducing disease progression and severity.

The inclusion of IBD in the NHF Card Programme, ensures access to essential medications, backed by an annual investment of approximately $29 million, significantly reducing out-of-pocket expenses and improving overall wellbeing.

Bladder cancer, though moderate in prevalence, presents a serious health risk with significant mortality rates. By covering key pharmaceutical treatments, the agency is providing critical support to those affected. This intervention is supported by an estimated $19 million annually, ensuring more consistent and accessible treatment pathways for patients.

“The NHF, through its public patient services in our pharmacies, in hospitals and elsewhere, as well as through the card, where private citizens can access support, will benefit from what this significant milestone represents,” said Minister of Health and Wellness, Dr. the Hon. Christopher Tufton.

He was speaking at the launch of the expansion, held today (March 18), at the Spanish Court Hotel in St. Andrew.

The Minister said that in addition to the expanded disease coverage, the Government through the NHF, is also strengthening diagnostic capabilities and essential effective healthcare, by introducing the echocardiogram benefit, a “major step forward in cardiovascular care”.

“Cardiovascular disease accounts for one third of deaths in Jamaica, and early accurate diagnosis is key to reversing this trend,” he said.

Dr. Tufton said that while a “host of programmes” are in the Ministry promoting screening, not enough Jamaicans screen and do their checkups, stressing that the NHF is making it easier for persons to get regular health checks, and over 365,000 NHF card beneficiaries, particularly those at high risk, such as individuals with hypertension or diabetes, will now have “greater access to this critical diagnostic tool”.

“The initiative represents about $34 million of annual expenditure, based on health economists modelling of the numbers that may take this up. This is a big opportunity, and in terms of prostate specific antigen (PSA), by expanding coverage from one to up to four subsidised PSA tests per year, we are addressing this gap directly, and this is expected to cost some $37 million for those individuals who take this up,” he said.

Minister Tufton told his audience that new benefits will build on the already “robust foundation” of the NHF, which includes medications across 24 chronic conditions with an average subsidy rate of some 54 per cent.